We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.86B
AUM Growth
+$83M
Cap. Flow
+$153M
Cap. Flow %
2.62%
Top 10 Hldgs %
16.53%
Holding
808
New
59
Increased
345
Reduced
246
Closed
48

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$28.5M
2
LUV icon
Southwest Airlines
LUV
+$19.5M
3
MCHP icon
Microchip Technology
MCHP
+$17.7M
4
MSFT icon
Microsoft
MSFT
+$16.8M
5
LOW icon
Lowe's Companies
LOW
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.16%
2 Technology 15.94%
3 Financials 14.63%
4 Consumer Discretionary 10.42%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARMO
401
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
$2.77M 0.05%
+74,000
New +$3.11M
VFC icon
402
VF Corp
VFC
$6.94B
$2.75M 0.05%
39,397
-31,140
-44% -$2.25M
MLM icon
403
Martin Marietta Materials
MLM
$34.8B
$2.74M 0.05%
13,230
+8,792
+198% +$1.91M
APLS
404
DELISTED
Apellis Pharmaceuticals
APLS
$2.74M 0.05%
124,000
+7,000
+6% +$138K
COL
405
DELISTED
Rockwell Collins
COL
$2.72M 0.05%
20,176
+5,080
+34% +$693K
PSA icon
406
Public Storage
PSA
$62.2B
$2.71M 0.05%
13,505
+689
+5% +$134K
BHVN
407
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.71M 0.05%
105,000
+25,000
+31% +$747K
SYRS
408
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.65M 0.05%
20,400
-600
-3% -$65.6K
GWPH
409
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.64M 0.05%
23,420
+420
+2% +$52.8K
MOS icon
410
The Mosaic Company
MOS
$7.3B
$2.64M 0.05%
108,551
+81,047
+295% +$2.13M
BAX icon
411
Baxter International
BAX
$12.5B
$2.62M 0.04%
40,319
-15,100
-27% -$1.02M
YUM icon
412
Yum! Brands
YUM
$41.1B
$2.62M 0.04%
30,730
-571
-2% -$46.8K
DG icon
413
Dollar General
DG
$27.9B
$2.61M 0.04%
27,858
+6,560
+31% +$630K
HBAN icon
414
Huntington Bancshares
HBAN
$34.8B
$2.6M 0.04%
172,297
+12,112
+8% +$190K
SLF icon
415
Sun Life Financial
SLF
$46.7B
$2.58M 0.04%
62,936
-1,852
-3% -$78.1K
NOW icon
416
ServiceNow
NOW
$115B
$2.58M 0.04%
77,815
+10,770
+16% +$332K
MAS icon
417
Masco
MAS
$16.7B
$2.56M 0.04%
63,242
+20,662
+49% +$887K
CPB icon
418
Campbell Soup
CPB
$6.82B
$2.54M 0.04%
58,696
+15,939
+37% +$718K
GIS icon
419
General Mills
GIS
$20.1B
$2.53M 0.04%
56,180
+415
+0.7% +$22.5K
CNQ icon
420
Canadian Natural Resources
CNQ
$92.3B
$2.51M 0.04%
163,211
+10,353
+7% +$166K
EQIX icon
421
Equinix
EQIX
$104B
$2.5M 0.04%
5,989
+137
+2% +$57.6K
COR icon
422
Cencora
COR
$61.9B
$2.49M 0.04%
28,852
+661
+2% +$63.5K
ANDV
423
DELISTED
Andeavor
ANDV
$2.49M 0.04%
24,727
-2,867
-10% -$299K
ROST icon
424
Ross Stores
ROST
$80.5B
$2.48M 0.04%
31,736
KSU
425
DELISTED
Kansas City Southern
KSU
$2.46M 0.04%
22,378
-113,547
-84% -$12.3M

Similar funds

Candriam SCA's Q1 2018 Portfolio in Review

As of Q1 2018, Candriam SCA held 808 positions worth $5.86B, up 1.4% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q1 2018 filing shows 59 new, 345 increased, 246 reduced and 48 closed positions. Its largest new stake was Ecopetrol: 700,000 shares worth $13.5M. The largest sale was Baidu, an estimated $28.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2018 buy was Ecopetrol: 700,000 shares worth $13.5M.
  • Candriam SCA added most to Biogen in Q1 2018, an estimated $50M increase.
  • Candriam SCA's biggest Q1 2018 reduction was Baidu, cutting an estimated $28.5M.
  • Candriam SCA fully exited Sociedad Química y Minera de Chile in Q1 2018, selling an estimated $13.4M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.86B portfolio in Q1 2018.
  • Candriam SCA opened 59 new positions and closed 48 in Q1 2018.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $5.86B.

Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.